GlassScriptPhysician profile
Praveen Kumar Vemuri
NPI 1598104234
$3,060.71
in general payments reported to CMS, 2019-2025
40 companies · $33.30 in 2025
The $33.30 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $513 · 2021: $944 · 2022: $27.43 · 2025: $33.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $33.30.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $33.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $360.11 | 2019-2021 | |
| Ucb, INC. | $242.50 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $195.74 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $169.66 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $169.65 | 2021 | |
| Genzyme Corporation | $169.59 | 2019-2021 | |
| Emd Serono, INC. | $162.48 | 2019-2020 | |
| Abbvie INC. | $159.08 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $151.55 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $134.41 | 2019-2021 | |
| Csl Behring | $121.02 | 2019-2021 | |
| Amgen INC. | $86.93 | 2019-2021 | |
| Allergan, INC. | $83.37 | 2020-2021 | |
| Amneal Pharmaceuticals LLC | $73.63 | 2019-2021 | |
| Biogen, INC. | $65.69 | 2019-2020 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $55.65 | 2019-2020 | |
| Bausch Health US, LLC | $46.92 | 2019 | |
| Mallinckrodt Hospital Products INC. | $40.34 | 2021 | |
| Alexion Pharmaceuticals, INC. | $39.21 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $37.42 | 2019 | |
| Eisai INC. | $36.20 | 2019-2021 | |
| Sk Life Science, INC. | $36.06 | 2021 | |
| Adamas Pharmaceuticals, INC. | $35.56 | 2020-2021 | |
| Celgene Corporation | $33.79 | 2020-2021 | |
| Pfizer INC. | $32.07 | 2019-2021 | |
| Kyowa Kirin, INC. | $31.83 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $31.51 | 2020 | |
| Abbott Laboratories | $31.18 | 2021 | |
| Viz.Ai, INC. | $27.43 | 2022 | |
| Avanir Pharmaceuticals, INC. | $23.42 | 2019 | |
| Neurocrine Biosciences, INC. | $22.21 | 2020 | |
| Upsher-Smith Laboratories LLC | $21.37 | 2020 | |
| Tanabe Pharma America, INC. | $20.31 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.26 | 2021 | |
| Arbor Pharmaceuticals, INC. | $17.69 | 2019 | |
| Aquestive Therapeutics, INC. | $17.31 | 2021 | |
| Lilly USA, LLC | $17.25 | 2020 | |
| Sanofi-Aventis U.S. LLC | $15.96 | 2021 | |
| Zyla Life Sciences, INC. | $13.38 | 2020 | |
| Greenwich Biosciences, INC. | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Praveen Vemuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.